Establishes the chief administrator of the courts shall submit annually a report on the administration, function and effectiveness of the Drug Treatment Court Program during the preceding year.
Same As
Establishes the chief administrator of the courts shall submit annually a report on the administration, function and effectiveness of the Drug Treatment Court Program during the preceding year.
Establishes the chief administrator of the courts shall submit annually a report on the administration, function and effectiveness of the Drug Treatment Court Program during the preceding year.
Establishes the chief administrator of the courts shall submit annually a report on the administration, function and effectiveness of the Drug Treatment Court Program during the preceding year.
Establishes the chief administrator of the courts shall submit annually a report on the administration, function and effectiveness of the Drug Treatment Court Program during the preceding year.
Establishes the chief administrator of the courts shall submit annually a report on the administration, function and effectiveness of the problem-solving courts during the preceding year.
Requires more specific data reporting by the chief administrator to include information relating to all courts in the unified court system, including town and village courts.
Requires more specific data reporting by the chief administrator to include information relating to all courts in the unified court system, including town and village courts.
Requires a report on the administration, function and outcomes of all superior courts for veterans treatment to be delivered to the legislature and the governor on or before March 15th every year beginning in 2028.
Directs the legislature to ensure that the number of judges and justices in districts and courts is sufficient; directs the chief administrator of the courts to report on the sufficiency of the number of judges and justices in each court and to make recommendations on such numbers.
Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug.